COMPANY

JAMP PHARMA CORPORATION

JAMP PHARMA CORPORATION: marketing authorisation holder for Bacitracin, Icatibant, Vancomycin, as stated by public registers.

MARKETING AUTHORISATION HOLDER

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

BacitracinANTIBIOTIC OINTMENT (DIN 02283425), Dormant Regulator Health Canada
BacitracinBACITRACINE 500 IU OINTMENT (DIN 02333562), Cancelled Post Market Regulator Health Canada
BacitracinJAMP-BACITRACINE (DIN 02351714), Dormant Regulator Health Canada
BacitracinJAMPOLYCIN (DIN 02357569), Dormant Regulator Health Canada
BacitracinTRIPLE ANTIBIOTIC OINTMENT (DIN 02248818), Dormant Regulator Health Canada
IcatibantICATIBANT INJECTION (DIN 02547562), Marketed Regulator Health Canada
VancomycinJAMP VANCOMYCIN (DIN 02407744), Marketed Regulator Health Canada
VancomycinJAMP VANCOMYCIN (DIN 02407752), Marketed Regulator Health Canada
VancomycinJAMP-VANCOMYCIN (DIN 02420295), Cancelled Post Market Regulator Health Canada
VancomycinJAMP-VANCOMYCIN (DIN 02420309), Cancelled Post Market Regulator Health Canada
VancomycinVANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (DIN 02420317), Dormant Regulator Health Canada
VancomycinVANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (DIN 02420325), Dormant Regulator Health Canada
VancomycinVANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (DIN 02502593), Marketed Regulator Health Canada
VancomycinVANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (DIN 02502607), Dormant Regulator Health Canada

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.